Our blog

Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest updates throughout the month of September.

Sadly, 25% of businesses fail within their first year and 65% of businesses fail within ten years. So, if you're thinking about starting a business or you've recently made the leap, how can you optimize your chances of success? 

In 2019, we partnered with one of the fastest-growing global pharmaceutical companies in Europe, to assist with hires for their generic drugs team. Following success across the generics team, in 2022, the client came to us to help hire for the launch of their first NCE.

Hollie Bevan interviewed Co-Founder of Neuronic Liam Pingree, delving into the team's unique technology, how the product was founded and upcoming plans for the team.

Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest updates throughout the month of August.

The question of funding size success has become increasingly relevant. Is the amount of funding always the key to breakthrough discoveries? Katie Davis explores the impact of funding size on research, development, and commercialization in the life science industry.

Tanya Ridding will soon be attending the LSI conference in Portugal, so in this blog, she walks you through some of the early-stage start-ups that VCs at 415 Capital, Sofinnova Partners, MIG Capital and SHS Capital believe are the ones to watch...

In this blog, we explore the latest updates throughout the month of July. You can subscribe to Katies biotech funding updates over on LinkedIn to keep up to date with the ever-growing biotech market.

It's a tradition that we bring together our offices for a summer party, fundraising for our Simone Taylor Fund. This year, we spun a wheel of fancy dress ideas & took to the infamous Otley Run in Leeds, raising for Target Ovarian Cancer.